Anna E. Barón

17.2k total citations · 2 hit papers
231 papers, 12.8k citations indexed

About

Anna E. Barón is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anna E. Barón has authored 231 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 50 papers in Pulmonary and Respiratory Medicine and 38 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anna E. Barón's work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (14 papers) and Cardiac, Anesthesia and Surgical Outcomes (13 papers). Anna E. Barón is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (14 papers) and Cardiac, Anesthesia and Surgical Outcomes (13 papers). Anna E. Barón collaborates with scholars based in United States, Italy and France. Anna E. Barón's co-authors include Wilbur A. Franklin, Paul A. Bunn, Chan Zeng, Marileila Varella‐Garcia, Robert Veve, Fred R. Hirsch, Roy M. Bremnes, Silvia Franceschi, Carlo La Vecchia and Michael V. Di Maria and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Circulation.

In The Last Decade

Anna E. Barón

225 papers receiving 12.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis

2003 1.2k citations Fred R. Hirsch, Marileila Varella‐Garcia et al. profile →
Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy.

1990 455 citations Anna E. Barón et al. PubMed profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Anna E. Barón	3.7k	3.6k	3.1k	1.6k	1.2k	231	12.8k
Theodore Karrison	3.0k 0.8×	3.8k 1.1×	3.6k 1.2×	2.1k 1.3×	1.3k 1.0×	322	14.5k
Robert T. Greenlee	3.0k 0.8×	4.3k 1.2×	2.6k 0.8×	2.0k 1.2×	1.3k 1.0×	116	12.8k
Ravi Bhatia	2.1k 0.6×	5.9k 1.6×	4.8k 1.5×	1.3k 0.8×	1.1k 0.9×	463	21.8k
Brian L. Egleston	2.9k 0.8×	2.6k 0.7×	2.0k 0.6×	2.6k 1.6×	1.0k 0.8×	243	11.6k
Judith D. Goldberg	2.4k 0.6×	2.2k 0.6×	2.4k 0.8×	3.0k 1.8×	1.5k 1.2×	397	16.0k
Wendy R. Parulekar	3.1k 0.8×	5.2k 1.4×	1.6k 0.5×	2.3k 1.4×	1.5k 1.2×	131	14.9k
Limin X. Clegg	3.7k 1.0×	6.6k 1.8×	1.8k 0.6×	2.7k 1.7×	2.2k 1.8×	44	16.7k
Howard T. Thaler	4.0k 1.1×	5.7k 1.6×	2.3k 0.7×	4.2k 2.6×	1.9k 1.5×	233	19.6k
Jayne F. Tierney	4.8k 1.3×	4.0k 1.1×	1.6k 0.5×	3.6k 2.2×	1.8k 1.5×	129	15.0k
Joan L. Kramer	3.3k 0.9×	6.4k 1.8×	4.8k 1.5×	1.4k 0.8×	970 0.8×	14	15.4k

Countries citing papers authored by Anna E. Barón

Since Specialization

Citations

This map shows the geographic impact of Anna E. Barón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna E. Barón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna E. Barón more than expected).

Fields of papers citing papers by Anna E. Barón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna E. Barón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna E. Barón. The network helps show where Anna E. Barón may publish in the future.

Co-authorship network of co-authors of Anna E. Barón

This figure shows the co-authorship network connecting the top 25 collaborators of Anna E. Barón. A scholar is included among the top collaborators of Anna E. Barón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna E. Barón. Anna E. Barón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barón, Anna E., Audrey Chagnot, A. Alvès, et al.. (2024). Avoidable general anesthesia for nonobstetric surgery during pregnancy: a retrospective cohort pilot study (2011–2020). International Journal of Obstetric Anesthesia. 61. 104265–104265.

Parikh, Rushi V., Anna E. Barón, Gary K. Grunwald, et al.. (2023). Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Journal of the American Heart Association. 12(4). e028082–e028082. 4 indexed citations

Kammer, Michael N., Stephen A. Deppen, Eric L. Grogan, et al.. (2022). The Intervention Probability Curve: Modeling the Practical Application of Threshold-Guided Decision-Making, Evaluated in Lung, Prostate, and Ovarian Cancers. Cancer Epidemiology Biomarkers & Prevention. 31(9). 1752–1759. 2 indexed citations

Josey, Kevin, Brandy M. Ringham, Anna E. Barón, et al.. (2021). Power for balanced linear mixed models with complex missing data processes. Communication in Statistics- Theory and Methods. 52(1). 46–64. 1 indexed citations

Graney, Bridget A., David H. Au, Anna E. Barón, et al.. (2019). Advancing Symptom Alleviation with Palliative Treatment (ADAPT) trial to improve quality of life: a study protocol for a randomized clinical trial. Trials. 20(1). 355–355. 18 indexed citations

Stanislawski, Maggie A., et al.. (2018). The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program. Clinical Cardiology. 41(6). 809–816. 6 indexed citations

Maron, Bradley A., Edward Hess, Thomas M. Maddox, et al.. (2016). Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circulation. 133(13). 1240–1248. 239 indexed citations

Merrick, Daniel T., Dexiang Gao, York E. Miller, et al.. (2015). Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma. Cancer Prevention Research. 9(1). 96–104. 24 indexed citations

Barón, Anna E., Nancy L. Asdigian, Victoria González, et al.. (2014). Interactions between Ultraviolet Light and MC1R and OCA2 Variants Are Determinants of Childhood Nevus and Freckle Phenotypes. Cancer Epidemiology Biomarkers & Prevention. 23(12). 2829–2839. 24 indexed citations

10.

Nasarre, Patrick, Robert M. Gemmill, Vincent Potiron, et al.. (2013). Neuropilin-2 Is Upregulated in Lung Cancer Cells during TGF-β1–Induced Epithelial–Mesenchymal Transition. Cancer Research. 73(23). 7111–7121. 55 indexed citations

11.

Malkoski, Stephen P., Sarah M. Haeger, Timothy G. Cleaver, et al.. (2012). Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma. Clinical Cancer Research. 18(8). 2173–2183. 52 indexed citations

12.

Mascaux, Céline, William J. Feser, Anna E. Barón, et al.. (2012). Endobronchial miRNAs as Biomarkers in Lung Cancer Chemoprevention. Cancer Prevention Research. 6(2). 100–108. 12 indexed citations

13.

Leng, Shuguang, Kieu Do, Christin M. Yingling, et al.. (2012). Defining a Gene Promoter Methylation Signature in Sputum for Lung Cancer Risk Assessment. Clinical Cancer Research. 18(12). 3387–3395. 78 indexed citations

14.

Schenkman, Margaret, Deborah A. Hall, Anna E. Barón, et al.. (2012). Exercise for People in Early- or Mid-Stage Parkinson Disease: A 16-Month Randomized Controlled Trial. Physical Therapy. 92(11). 1395–1410. 158 indexed citations

15.

Varella‐Garcia, Marileila, Holly J. Wolf, William J. Feser, et al.. (2010). The Detection of Chromosomal Aneusomy by Fluorescence In situ Hybridization in Sputum Predicts Lung Cancer Incidence. Cancer Prevention Research. 3(4). 447–453. 38 indexed citations

16.

Micalizzi, Douglas S., Kimberly Christensen, Paul Jedlicka, et al.. (2009). The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling. Journal of Clinical Investigation. 119(9). 2678–2690. 196 indexed citations

17.

Nieto, Yago, James J. Vredenburgh, Elizabeth J. Shpall, et al.. (2004). Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer. Clinical Cancer Research. 10(21). 7136–7143. 12 indexed citations

18.

Shlay, Judith C., et al.. (2003). Initiating contraception in sexually transmitted disease clinic setting: a randomized trial. American Journal of Obstetrics and Gynecology. 189(2). 473–481. 22 indexed citations

19.

Bunn, Paul A., B. Helfrich, Wilbur A. Franklin, et al.. (2001). Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.. PubMed. 7(10). 3239–50. 131 indexed citations

20.

Judson, Franklyn N., et al.. (1996). Usefulness of Human Immunodeficiency Virus Post-Test Counseling by Telephone for Low-Risk Clients of an Urban Sexually Transmitted Diseases Clinic. Sexually Transmitted Diseases. 23(3). 190–197. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact